Androisoxazole Explained

Androisoxazole (brand names Androxan, Neo-Ponden, Neo-Pondus), also known as 17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of dihydrotestosterone (DHT) that is marketed in Spain and Italy.[1] [2] [3] [4] It is closely related to stanozolol, differing only in having an isoxazole instead of pyrazole ring fused to the A ring, and is also related to furazabol, prostanozol, and danazol.

Notes and References

  1. Book: Index Nominum 2000: International Drug Directory. January 2000. Taylor & Francis. 978-3-88763-075-1. 63–.
  2. Book: Charles D. Kochakian. Anabolic-Androgenic Steroids. 6 December 2012. Springer Science & Business Media. 978-3-642-66353-6. 384–.
  3. ANTONINI FM, VERDI G . [Preliminary results of experience with a new anabolic steroid, "androisoxazole," in the aged.] . it . Minerva Medica . 52 . 3437–41 . October 1961 . 13861810 .
  4. ARNOLD A, POTTS GO, BEYLER AL . Relative Oral Anabolic to Androgenic Activity Ratios of Androisoxazole, Ethylestrenol, Methylandrostenolisoxazole and Testosterone . Acta Endocrinologica . 44 . 4. 490–8 . December 1963 . 14082537 . 10.1530/acta.0.0440490.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Androisoxazole".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.